Stay updated on Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdministrative updates: Revision: v3.4.2 has been added; the notice about a lapse in government funding has been removed along with Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedSite-wide notice about government funding lapse and operating status, and a page revision note (Revision: v3.4.1) were added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and a new label 'Last Update Submitted that Met QC Criteria'. Updated capitalization for 'No FEAR Act Data' and related labels, and changed the revision tag to 'Revision: v3.4.0' (replacing 'v3.3.4').SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedFooter revision notice updated to Revision: v3.3.3. The HHS Vulnerability Disclosure link and the old Revision: v3.3.2 notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the ClinicalTrials.gov page. The core study details remain unchanged.SummaryDifference0.0%

Stay in the know with updates to Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.